Albert Jang

1.2k total citations
44 papers, 478 citations indexed

About

Albert Jang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Albert Jang has authored 44 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Albert Jang's work include Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (11 papers) and Renal cell carcinoma treatment (8 papers). Albert Jang is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (11 papers) and Renal cell carcinoma treatment (8 papers). Albert Jang collaborates with scholars based in United States, Italy and Canada. Albert Jang's co-authors include Oliver Sartor, A. Tuba Kendi, Min Chen, Jin Wang, Pedro C. Barata, Srikanth Kodali, Geoffrey B. Johnson, Þorvarður R. Hálfdánarson, Michael W. Conner and Jordan J. Karlitz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Albert Jang

39 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Jang United States 13 147 123 115 103 96 44 478
Ilaria Rossi Italy 9 78 0.5× 163 1.3× 103 0.9× 79 0.8× 139 1.4× 19 640
Lucie McCoy United States 15 102 0.7× 104 0.8× 93 0.8× 45 0.4× 176 1.8× 36 752
Xiao‐Nan Tao China 12 168 1.1× 200 1.6× 86 0.7× 31 0.3× 133 1.4× 39 727
Weichen Lin China 8 137 0.9× 89 0.7× 57 0.5× 96 0.9× 154 1.6× 13 694
Xiaobei Chen China 9 64 0.4× 168 1.4× 55 0.5× 31 0.3× 114 1.2× 20 531
Frank Aboubakar Nana Belgium 14 171 1.2× 184 1.5× 21 0.2× 50 0.5× 107 1.1× 29 510
Kai Dai China 10 66 0.4× 176 1.4× 91 0.8× 28 0.3× 72 0.8× 19 484
Liang Shao China 14 48 0.3× 116 0.9× 84 0.7× 40 0.4× 208 2.2× 32 645
Yasuhiro Gushima Japan 10 419 2.9× 50 0.4× 149 1.3× 32 0.3× 61 0.6× 13 589
Moo Hyun Lee South Korea 13 93 0.6× 160 1.3× 74 0.6× 42 0.4× 119 1.2× 27 552

Countries citing papers authored by Albert Jang

Since Specialization
Citations

This map shows the geographic impact of Albert Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Jang more than expected).

Fields of papers citing papers by Albert Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Jang. The network helps show where Albert Jang may publish in the future.

Co-authorship network of co-authors of Albert Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Jang. A scholar is included among the top collaborators of Albert Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Jang. Albert Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Albert, Prateek Jain, Adam Calaway, et al.. (2025). Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure?. The Oncologist. 30(9).
2.
Jang, Albert, Jorge A. García, Norbert Avril, et al.. (2024). Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer. Advances in cancer research. 164. 311–358. 2 indexed citations
3.
Jang, Albert, et al.. (2024). Papillary Renal Cell Carcinoma: Current Evidence and Future Directions. PubMed. 8(1). 61–79. 1 indexed citations
4.
Jang, Albert, A. Tuba Kendi, Geoffrey B. Johnson, Þorvarður R. Hálfdánarson, & Oliver Sartor. (2023). Targeted Alpha-Particle Therapy: A Review of Current Trials. International Journal of Molecular Sciences. 24(14). 11626–11626. 55 indexed citations
5.
Jang, Albert, Patrick J. O. Miller, Jodi Lyn Layton, et al.. (2023). Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate‐resistant prostate cancer post‐abiraterone and/or enzalutamide. The Prostate. 83(11). 1028–1034. 3 indexed citations
6.
Jang, Albert, Patrick J. O. Miller, Pedro C. Barata, et al.. (2023). Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 41(6_suppl). 246–246. 1 indexed citations
7.
Jang, Albert, Jake Lichterman, Jonathan E. Shoag, et al.. (2023). Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Human Vaccines & Immunotherapeutics. 19(3). 2276629–2276629. 4 indexed citations
8.
Sartor, Oliver, Elisa M. Ledet, Brian Lewis, et al.. (2023). Prediction of Resistance to177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers. Journal of Nuclear Medicine. 64(11). 1721–1725. 12 indexed citations
9.
Hoffman, Kristi L., Anthony Xu, Donna L. White, et al.. (2023). The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans—A Preliminary Investigation. Nutrients. 15(7). 1747–1747. 14 indexed citations
10.
Jang, Albert, Patrick J. O. Miller, Pedro C. Barata, et al.. (2023). Genomic alterations in patients with prostate cancer with liver metastases.. Journal of Clinical Oncology. 41(6_suppl). 248–248. 1 indexed citations
11.
Jang, Albert, et al.. (2023). PSMA PET/CT Detection of Chondromyxoid Fibroma. Clinical Nuclear Medicine. 48(6). 545–546. 1 indexed citations
12.
Jang, Albert, Elisa M. Ledet, Brian Lewis, et al.. (2022). Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience. Clinical Genitourinary Cancer. 21(2). e9–e18. 1 indexed citations
13.
Jang, Albert, et al.. (2022). Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer. OncoTargets and Therapy. Volume 15. 897–912. 3 indexed citations
14.
Jang, Albert, et al.. (2022). Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials. Cancer Treatment and Research Communications. 33. 100639–100639. 5 indexed citations
15.
16.
17.
Xie, John, et al.. (2021). Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.. SHILAP Revista de lepidopterología. 15. 100247–100247. 6 indexed citations
18.
Jang, Albert, et al.. (2021). Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus. Frontiers in Immunology. 12. 701066–701066. 10 indexed citations
19.
Jang, Albert, et al.. (2020). Acute Lymphoblastic Leukemia Presenting Initially as Spinal Cord Compression: When Chemotherapy Alone Is Enough. SHILAP Revista de lepidopterología. 2020. 1–5. 4 indexed citations
20.
Ajami, Nadim J., David Y. Graham, Donna L. White, et al.. (2020). Alcohol use alters the colonic mucosa–associated gut microbiota in humans. Nutrition Research. 83. 119–128. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Rossi Breakdown of academic impact, for papers by Lucie McCoy Breakdown of academic impact, for papers by Xiao‐Nan Tao Breakdown of academic impact, for papers by Weichen Lin Breakdown of academic impact, for papers by Xiaobei Chen Breakdown of academic impact, for papers by Frank Aboubakar Nana Breakdown of academic impact, for papers by Kai Dai Breakdown of academic impact, for papers by Liang Shao Breakdown of academic impact, for papers by Yasuhiro Gushima Breakdown of academic impact, for papers by Moo Hyun Lee
Rankless by CCL
2026